Product Information
LIDOCAINE HCL 2% 100 MG/5 ML is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3634 per ML under NDC 31722011832. Its NADAC has been published 61 times since Jul 23, 2025.
FDA first approved this application on Nov 8, 2021. Its Orange Book therapeutic-equivalence code is AP.
Strength
20 mg/mL
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722011832
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL
Effective Date
9/17/2025
Active Ingredients
LIDOCAINE HYDROCHLORIDE ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA214339FDA Approved
11/8/2021
TE Code
AP
On Market Since
11/8/2021
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 2% 100 MG/5 ML has been published 61 times since Jul 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3634 per ML |
|---|---|
| All-time high | $0.3634 (Sep 16, 2026) |
| All-time low | $0.3634 (Jul 23, 2025) |
| 52-week high | $0.3634 |
| 52-week low | $0.3634 |
| Median price | $0.3634 |
| Average price | $0.3634 |
| Largest weekly change | 0.0% (Jul 30, 2025) |
| Weeks tracked | 61 |
| Tracking since | Jul 23, 2025 |
1W
N/A
1M
0.0%
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Sep 16, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 79% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 2% 100 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 2% 100 MG/5 ML, manufactured by Camber Pharmaceuticals Inc., is $0.3634 per ML (NDC 31722011832), effective Sep 16, 2026.
How has the price of LIDOCAINE HCL 2% 100 MG/5 ML changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 2% 100 MG/5 ML has held within roughly two percent of its current level. It has been tracked across 61 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 2% 100 MG/5 ML?
Since Jul 23, 2025, the NADAC for LIDOCAINE HCL 2% 100 MG/5 ML has ranged from a low of $0.3634 (Jul 23, 2025) to a high of $0.3634 (Sep 16, 2026), with a median of $0.3634 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 2% 100 MG/5 ML?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 2% VIAL, is $0.0762 per ML — about 79% below LIDOCAINE HCL 2% 100 MG/5 ML.
Who manufactures LIDOCAINE HCL 2% 100 MG/5 ML?
LIDOCAINE HCL 2% 100 MG/5 ML (NDC 31722011832) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.